Leo pharma announces positive phase 3 head-to-head data results from delta force trial comparing delgocitinib cream with alitretinoin capsules in adults with severe chronic hand eczema (che)

Ballerup, denmark--(business wire)--leo pharma announces positive phase 3 head-to-head data results from delta force trial comparing delgocitinib cream with alitretinoin capsules.
DAL Ratings Summary
DAL Quant Ranking